Unveiling the Potential of Enzyme Replacement Therapy (ERT) in Rare Genetic Disorders
The global Enzyme Replacement Therapy (ERT) Market was valued at USD 13.08 billion in 2022 and is projected to experience a rapid revenue compound annual growth rate (CAGR) of 9% during the forecast period. This growth can be attributed to advancements in biotechnology, the increasing prevalence of rare genetic diseases, and the growing demand for effective treatment options. ERT utilizes...
0 Comments 0 Shares 1220 Views
Sponsored